Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.41−0.29 (-3.77%)
Close on Nov 17, 2026Market cap $671.08MP/E –Yield –
Verastem cash
Cash and short-term investments held at the end of each period.
Verastem's cash was $136.40M at Jun 30, 2026. For fiscal 2025 it was $205.00M, up 130.9% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $249.70M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $205.00M | +130.9% |
| FY2024 | Dec 31, 2024 | $88.80M | -35.8% |
| FY2023 | Dec 31, 2023 | $138.30M | +57.3% |
| FY2022 | Dec 31, 2022 | $87.90M | -12.4% |
| FY2021 | Dec 31, 2021 | $100.30M | -32.0% |
| FY2020 | Dec 31, 2020 | $147.50M | +32.5% |
| FY2019 | Dec 31, 2019 | $111.30M | -55.4% |
| FY2018 | Dec 31, 2018 | $249.70M | +188.0% |
| FY2017 | Dec 31, 2017 | $86.70M | +7.2% |
| FY2016 | Dec 31, 2016 | $80.90M | -26.6% |
| FY2015 | Dec 31, 2015 | $110.26M | +19.0% |
| FY2014 | Dec 31, 2014 | $92.68M | -8.5% |
| FY2013 | Dec 31, 2013 | $101.31M | +79.1% |
| FY2012 | Dec 31, 2012 | $56.58M | -6.9% |
| FY2011 | Dec 31, 2011 | $60.76M | +1595.3% |
| FY2010 | Dec 31, 2010 | $3.58M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $136.40M | -17.0% |
| Q1 FY2026 | Mar 31, 2026 | $181.70M | +54.5% |
| Q4 FY2025 | Dec 31, 2025 | $205.00M | +130.9% |
| Q3 FY2025 | Sep 30, 2025 | $137.70M | +21.6% |
| Q2 FY2025 | Jun 30, 2025 | $164.30M | +97.0% |
| Q1 FY2025 | Mar 31, 2025 | $117.60M | -15.0% |
| Q4 FY2024 | Dec 31, 2024 | $88.80M | -46.4% |
| Q3 FY2024 | Sep 30, 2024 | $113.20M | -38.2% |
| Q1 FY2024 | Jun 30, 2024 | $83.40M | -25.0% |
| Q4 FY2023 | Dec 31, 2023 | $138.30M | +57.3% |
| Q3 FY2023 | Sep 30, 2023 | $165.70M | +59.3% |
| Q2 FY2023 | Jun 30, 2023 | $183.10M | +94.2% |
| Q1 FY2023 | Mar 31, 2023 | $111.20M | +4.6% |
| Q4 FY2022 | Dec 31, 2022 | $87.90M | -12.4% |
| Q3 FY2022 | Sep 30, 2022 | $104.00M | +0.6% |
| Q2 FY2022 | Jun 30, 2022 | $94.30M | -17.4% |
| Q1 FY2022 | Mar 31, 2022 | $106.30M | -16.4% |
| Q4 FY2021 | Dec 31, 2021 | $100.30M | -32.0% |
| Q3 FY2021 | Sep 30, 2021 | $103.40M | -49.7% |
| Q2 FY2021 | Jun 30, 2021 | $114.10M | -29.0% |
| Q1 FY2021 | Mar 31, 2021 | $127.10M | -25.5% |
| Q4 FY2020 | Dec 31, 2020 | $147.50M | +32.5% |
| Q3 FY2020 | Sep 30, 2020 | $205.70M | +28.4% |
| Q2 FY2020 | Jun 30, 2020 | $160.80M | -14.1% |
| Q1 FY2020 | Mar 31, 2020 | $170.70M | -19.4% |
| Q4 FY2019 | Dec 31, 2019 | $111.30M | -55.4% |
| Q3 FY2019 | Sep 30, 2019 | $160.20M | +10.0% |
| Q2 FY2019 | Jun 30, 2019 | $187.30M | +10.8% |
| Q1 FY2019 | Mar 31, 2019 | $211.70M | +227.6% |
| Q4 FY2018 | Dec 31, 2018 | $249.70M | +188.0% |
| Q3 FY2018 | Sep 30, 2018 | $145.60M | +141.6% |
| Q2 FY2018 | Jun 30, 2018 | $169.10M | +192.0% |
| Q1 FY2018 | Mar 31, 2018 | $64.62M | -11.0% |
| Q4 FY2017 | Dec 31, 2017 | $86.70M | +7.2% |
| Q3 FY2017 | Sep 30, 2017 | $60.26M | -30.6% |
| Q2 FY2017 | Jun 30, 2017 | $57.92M | -37.6% |
| Q1 FY2017 | Mar 31, 2017 | $72.57M | – |
| Q4 FY2016 | Dec 31, 2016 | $80.90M | – |
| Q3 FY2016 | Sep 30, 2016 | $86.88M | – |
| Q2 FY2016 | Jun 30, 2016 | $92.87M | – |
See a number that looks wrong?